Toronto, Canada

Michael Kolios

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Kolios: Innovator in Cancer Imaging and Treatment

Introduction

Michael Kolios is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of cancer treatment and imaging. His innovative work focuses on enhancing the effectiveness of cancer therapies through advanced imaging techniques and drug delivery systems.

Latest Patents

Michael Kolios holds a patent for "Cancer imaging methods and cancer treatment methods using thermotherapy and drug delivery." This patent outlines various methods for determining the temperature of heated tissue using radio-frequency data from ultrasound transducers. It also describes the administration of nanocarriers containing anti-tumor medications, which can be excited using ultrasound to improve treatment efficacy. Additionally, the patent includes methods for using photoacoustic imaging to monitor the temperature of heated tissue at tumor sites.

Career Highlights

Throughout his career, Michael Kolios has been dedicated to advancing cancer treatment methodologies. His work has led to the development of innovative techniques that combine imaging and therapeutic approaches, significantly impacting patient care. He is associated with Cancer Rx, LLC, where he continues to push the boundaries of cancer research and treatment.

Collaborations

Michael Kolios has collaborated with notable professionals in his field, including Gholam A Peyman and Celina Yang. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge cancer treatment technologies.

Conclusion

Michael Kolios is a key figure in the realm of cancer imaging and treatment, with a focus on innovative methodologies that improve patient outcomes. His contributions to the field are invaluable, and his ongoing work promises to lead to further advancements in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…